Analyst Ratings for Fate Therapeutics (FATE)
FATE Rating Summary
FATE Price Target Summary
- Highest: $11.00 (Canaccord Genuity)
- Lowest: $5.00 (Wells Fargo)
- Average: $7.44
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$7.44 (+41.3%)
* Over Last 12-Mos
Rating Score: 3.5 / 10
Percentile Rank: 33%
Rating Score: 3.5 / 10
Percentile Rank: 33%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/27/2023 | Wells Fargo » Updated 11/9/2023 |
Yanan Zhu | New Coverage | Equal Weight (N/A) |
5.00 (6.00) |
5.39 (5.27) |
-2.23% | Details |
| 1/24/2023 | H.C. Wainwright | Debjit Chattopadhyay | Downgrade | Neutral (Buy) |
N/A (N/A) |
5.55 (5.27) |
-5.05% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
